Article thumbnail

Characterization of the Escherichia coli Antifungal Protein PPEBL21

By V. Yadav, R. Mandhan, M. Kumar, J. Gupta and G. L. Sharma


An antifungal protein isolated from Escherichia coli BL21 (PPEBL21) and predicted to be alcohol dehydrogenase (ADH) was subjected to biological characterization. The PPEBL21, indeed, demonstrated propionaldehyde-specific ADH activity. The Km and Vmax of PPEBL21 were found to be 644.8 μM and 1.2 U/mg, respectively. In-gel activity assay also showed that PPEBL21 was a propionaldehyde-specific ADH. The pI of PPEBL21 was observed to be 7.8. PPEBL21 was found to be stable up to a temperature of 40°C with optimum activity at pH 7.5. The decrease in pH decreased the activity of PPEBL21. These results suggested that PPEBL21 having alcohol dehydrogenase activity and stability at significantly high temperature might be an important lead antifungal molecule. Experiments were performed to identify the possible target of PPEBL21 in the pathogen A. fumigatus. Results revealed that PPEBL21 inhibited completely the expression of a 16 kDa protein in A. fumigatus. The 16 kDa protein of A. fumigatus targeted by PPEBL21 was identified as a hypothetical protein by peptide mass fingerprinting. It is thus hypothesized that a 16 kDa factor is essentially required by A. fumigatus for survival and its impaired synthesis due to treatment with PPEBL21 may lead to the death of pathogen

Topics: Research Article
Publisher: Hindawi Publishing Corporation
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2004). A novel antifungal pyrrole derivative from Datura metel leaves,”
  2. (2005). An antifungal fraction from Escherichia coli,”
  3. (2007). An antifungal protein from Escherichia coli,”
  4. (1996). Antifungal agents: chemotherapeutic targets and immunologic strategies,”
  5. (1998). Antifungal therapy in bone marrow failure,”
  6. (2009). Differential expression of Aspergillus fumigatus p r o t e i ni nr e s p o n s e to treatment with a novel antifungal compound, diethyl 4-(4-methoxyphenyl)-2,6-dimethyl-1,4-dihydropyridin3,5-dicarboxylate,” Mycoses,
  7. (1995). e v a n ,H .R y d e r ,a n dI .S h a w ,“ I d e n t i f y i n gs m a l l - m o l e c u l e lead compounds: the screening approach to drug discovery,”
  8. (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications,”
  9. (2000). Enzymkinetik Theorie und Methoden,
  10. (1974). etal.,“Thestructure ofhorseliveralcoholdehydrogenase,”FEBSLetters,vol.44,pp.
  11. (1977). Evidence for two-step binding of reduced nicotinamideadeninedinucleotidetoaldehydedehydrogenase,”
  12. (2003). Expression, localization and potential physiological significance of alcohol dehydrogenase in the gastrointestinal tract,”
  13. (1994). G a o ,H .T .C a o ,R .H .J i ,a n dZ .C .Z h a n g,“ I s o l a t i o na n d characterization of protein-biosynthesis inhibiting proteins from seeds of luffa cylindrica,”
  14. (2004). Kinetic properties of native and mutagenized isoforms of mitochondrial alcohol dehydrogenase III purified from Kluyveromyces lactis,”
  15. (2001). Lactobacillus coryniformis subsp. coryniformis strain Si3 produces a broad-spectrum proteinaceous antifungal compound,”
  16. (1994). Molecular characterization of microbial alcohol dehydrogenases,”
  17. (2000). Nicotinoprotein (NADHcontaining) alcohol dehydrogenase from Rhodococcus erythropolis DSM 1069: an efficient catalyst for coenzymeindependent oxidation of a broad spectrum of alcohols and the interconversion of alcohols and aldehydes,”
  18. (1987). Preclinical evaluation of antifungal agents,” in Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents,R .A .F r o m t l i
  19. (2004). Production of an antifungal protein for control of Colletotrichum lagenarium by Bacillus amyloliquefaciens MET0908,”
  20. (1990). Protein engineering of alcohol dehydrogenases: effects of amino acid changes at positions 93 and 48 of yeast
  21. (1976). Purification and properties of ap o l y o ld e h y d r o g e n a s ef r o mCephalosporium chrysogenus,”
  22. (1988). Purification and properties of primary and secondary alcohol dehydrogenases from Thermoanaerobacter ethanolicus,”
  23. (2002). Studies on antimycotic properties of Datura metel,”
  24. (1969). Studies on the allergenic fungal spores of the Delhi, India, metropolitan area. Clinical aspects,”
  25. (1981). Substrate specificity and stereospecificity of nicotinamide adenine dinucleotide-linked alcohol dehydrogenases from methanol-grown yeasts,”
  26. (1995). The fungal cell wall as a drug target,”
  27. (2002). W o o ,E .K i t a m u r a ,H .M y u o g a ,a n dK .Y u t o ,“ A n antifungal protein from the marine bacterium Streptomyces species strain AP 77 is specific for Pythium Porphyrae,a causative agent of red rot disease in Porphyra spp,”
  28. (1955). Zinc, a component of yeast alcohol dehydrogenase,”